You are here: Industry Insights > Plasticell

News List

Plasticell leads gene therapy manufacturing consortium biospectrumasia
June 27, 2018
UK’s innovation agency provides funding to develop advanced technologies for the manufacturing of autologous ex vivo gene therapies.
Plasticell and GSK collaborate to produce hematopoietic cells from iPSCs pharmaasia
October 26, 2017
Plasticell will contribute its CombiCult®stem cell screening technology to optimise iPSC specification for GSK research use.
Plasticell in collaboration with GSK expressbpd
October 19, 2017
Plasticell, the biotechnology company specialising in stem cell screening and cell therapy development, has entered into a collaboration with GSK to use its combinatorial stem cell screening technology
GSK, Plasticell sign deal to produce haematopoietic cells pharmatimes
October 19, 2017
GlaxoSmithKline and Plasticell have signed a collaboration agreement to produce haematopoietic cells from induced pluripotent stem cells (iPSCs).
GSK collaborates with Plasticell for stem cell technology biospectrumasia
October 18, 2017
In the collaboration, Plasticell will use its CombiCult technology to screen combinations of molecules provided by GSK to identify and optimise iPSC differentiation protocols.
UK’s Innovation Agency Backs Plasticell contractpharma
April 14, 2017
Cell therapy producer will make red blood cell substitute from pluripotent stem cells
Plasticell Signs Stem Cell Research Collaborations contractpharma
March 30, 2017
Plasticell has signed agreements with the Agency for Science, Technology and Research (A*STAR) and the Nanyang Technological University (NTU) to progress its therapeutic stem cell pipeline.